RMV LSE Week ended 07 Aug 2026

Weekly Investor Report

Rightmove plc · Communication Services · Internet Content & Information

Open interactive chart View report data
Latest close 473.0 GBP
1.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 6.2% above the Trend Line and sits at 20.3% of its 52-week range. The latest completed week returned 1.8%, after a 8.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 56/100.

Setup score 37 out of 100
Latest Close 473.0 GBP 7 Aug 2026
1W Return 1.8% latest completed week
4W Return 8.9% short-term follow-through
12W Return 17.1% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 43.38% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.8% Latest completed week; four-week move 8.9%. Indicator stack 5/79 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.38% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 34 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 6.2% above the Trend Line and sits at 20.3% of its 52-week range. The latest completed week returned 1.8%, after a 8.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1112-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals5Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 8.9% over four weeks, 17.1% over 12 weeks, and -40.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.8%
4W8.9%
12W17.1%
26W5.6%
52W-40.0%
Active trend streak0 weeks
Active weeks in one year5
Trend breadth9.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.43Latest activity-pressure read.
Pressure change36.4%Four-week change in activity pressure.
Leadership-17.84Latest relative-leadership reading.
RS change32.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 88% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value7/100Relative valuation strength. Underlying universe rank 94; rank 1 is best.
Quality100/100Profitability and accounting quality. Underlying universe rank 1; rank 1 is best.
Momentum2/100Medium-term price momentum. Underlying universe rank 99; rank 1 is best.
Growth86/100Revenue and earnings growth. Underlying universe rank 15; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
16.1x
Price divided by trailing earnings.
Price / sales
8.2x
Market value relative to trailing revenue.
EV / EBITDA
11.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
67.7%
Operating profit retained from revenue.
Free-cash-flow margin
53.2%
Free cash flow generated from revenue.
Return on invested capital
412.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
9.0%
Latest one-year revenue growth.
EPS growth
15.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
11.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.2%
Cash dividends relative to market value.
Buyback yield
4.0%
Net share repurchases relative to market value.
Shareholder yield
6.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 34 relevant articles.

13 positive · 16 neutral · 5 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.3%Distance below the 52-week high.
13-week volatility4.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+9.1%Week of 22 May.
Worst week-6.9%Week of 20 Mar.
Latest week+1.8%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses8
Sharp losses5
Recent vol4.4%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split17/35Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 43.38%

Next-week expectancy is negative with a 43.38% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 16 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment56/100

Weighted news tone is neutral across 34 relevant articles.

Explore Rightmove (LSE:RMV): What’s Driving Market Attention? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026473.0 GBP1.8%445.3 GBP585.5 GBP1.43-17.8430.0MOff
31 Jul 2026464.6 GBP6.2%446.7 GBP586.1 GBP1.28-20.3118.9MOff
24 Jul 2026437.3 GBP-3.0%448.3 GBP586.8 GBP1.16-25.3225.9MOff
17 Jul 2026451.0 GBP3.8%450.9 GBP587.6 GBP1.15-23.2119.2MOff
10 Jul 2026434.3 GBP-3.4%453.3 GBP588.3 GBP1.05-26.5016.5MOff
3 Jul 2026449.4 GBP2.1%456.6 GBP588.9 GBP0.91-26.401.8MOff
26 Jun 2026440.0 GBP5.3%459.7 GBP589.4 GBP0.85-27.888.0MOff
19 Jun 2026417.9 GBP-1.9%463.3 GBP589.9 GBP0.78-31.6229.1MOff
12 Jun 2026426.2 GBP-2.9%467.6 GBP590.5 GBP0.78-32.042.6MOff
5 Jun 2026438.8 GBP4.6%471.7 GBP591.2 GBP0.70-30.378.6MOff
29 May 2026419.7 GBP-4.7%476.2 GBP591.7 GBP0.60-34.5618.1MOff
22 May 2026440.6 GBP9.1%484.5 GBP592.4 GBP0.53-32.6122.1MOff
15 May 2026404.0 GBP-4.4%492.7 GBP593.0 GBP0.44-37.4415.5MOff
8 May 2026422.4 GBP-1.6%501.8 GBP594.0 GBP0.51-35.7518.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context